Trial Profile
A Phase 1, Open Label, Single Dose, Randomized, Cross-Over Study To Estimate The Effect Of Esomeprazole On The Pharmacokinetics Of Crizotinib In Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Apr 2022
Price :
$35
*
At a glance
- Drugs Crizotinib (Primary) ; Esomeprazole
- Indications Anaplastic large cell lymphoma; Bladder cancer; Glioblastoma; Neuroblastoma; Non-Hodgkin's lymphoma; Non-small cell lung cancer; Prostate cancer; Renal cell carcinoma; Solid tumours
- Focus Pharmacokinetics
- 04 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 May 2012 Actual initiation date (May 2012) added as reported by ClinicalTrials.gov.
- 29 May 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.